Refractory pruritus from malignant cholestasis: management

dc.contributor.author	Fernando, G.V.M.C.
dc.contributor.author	Preston, N.
dc.date.accessioned	2022-09-15T05:13:08Z
dc.date.available	2022-09-15T05:13:08Z
dc.date.issued	2020
dc.identifier.citation	Fernando, G.V.M.C. & Preston, N. (2020). Refractory pruritus from malignant cholestasis: management. BMJ Supportive & Palliative Care 2020;0:1–3.	en_US
dc.identifier.uri	http://dr.lib.sjp.ac.lk/handle/123456789/12285
dc.description.abstract	This case report deals with a patient managed in a tertiary-care cancer hospital who suffered pruritus associated with malignant cholestasis. His symptoms were resistant to conventional treatment with ursodeoxycholic acid, chlorpheniramine and cholestyramine. Hence, the multifactorial origin of malignancyassociated pruritus was considered. Correctable factors were corrected and generally the treatment was aimed at possible aetiologies. There were barriers related to insufficient resources available for symptom palliation in this particular setting, which could potentially reduce optimum symptom control. However, various pharmacotherapies and non-pharmacological measures which could potentially have helped relieve pruritus are described and future scope for research in this area discussed	en_US
dc.language.iso	en	en_US
dc.publisher	BMJ	en_US
dc.title	Refractory pruritus from malignant cholestasis: management	en_US
dc.type	Article	en_US